Soltis Investment Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.59M Buy
27,252
+1,303
+5% +$465K 0.6% 36
2025
Q4
$8.49M Buy
25,949
+1,047
+4% +$332K 0.56% 39
2025
Q3
$7.03M Buy
24,902
+6,345
+34% +$1.84M 0.49% 52
2025
Q2
$5.18M Buy
18,557
+697
+4% +$197K 0.41% 64
2025
Q1
$5.56M Buy
17,860
+15,528
+666% +$4.59M 0.5% 54
2024
Q4
$608K Sell
2,332
-44
-2% -$13.1K 0.06% 220
2024
Q3
$766K Buy
2,376
+352
+17% +$115K 0.07% 174
2024
Q2
$632K Sell
2,024
-395
-16% -$116K 0.07% 186
2024
Q1
$688K Sell
2,419
-18
-0.7% -$5.27K 0.08% 170
2023
Q4
$702K Buy
2,437
+61
+3% +$16.6K 0.08% 158
2023
Q3
$639K Buy
2,376
+302
+15% +$75.4K 0.08% 159
2023
Q2
$461K Buy
2,074
+804
+63% +$187K 0.05% 176
2023
Q1
$307K Buy
1,270
+284
+29% +$69.7K 0.04% 209
2022
Q4
$259K Hold
986
0.03% 215
2022
Q3
$222K Buy
986
+30
+3% +$7.27K 0.03% 211
2022
Q2
$233K Buy
956
+44
+5% +$10.8K 0.03% 210
2022
Q1
$221K Sell
912
-950
-51% -$218K 0.03% 232
2021
Q4
$419K Buy
+1,862
New +$393K 0.06% 180
2021
Q3
Sell
-1,086
Closed -$265K 244
2021
Q2
$265K Sell
1,086
-2,654
-71% -$653K 0.04% 210
2021
Q1
$931K Buy
3,740
+1,398
+60% +$334K 0.17% 104
2020
Q4
$538K Buy
+2,342
New +$540K 0.1% 135

Other funds holding AMGN

Soltis Investment Advisors's AMGN Position: Q1 2026 in Review

Soltis Investment Advisors increased its Amgen (AMGN) stake by 5% in Q1 2026, buying an estimated $465K and bringing the position to 27,252 shares worth $9.59M. The position accounts for 0.6% of the portfolio, ranked #36.

Soltis Investment Advisors first reported a position in AMGN in Q4 2020 and has held it in 21 quarters since. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Soltis Investment Advisors held 27,252 shares of Amgen worth $9.59M as of Q1 2026.
  • Soltis Investment Advisors bought 1,303 Amgen shares in Q1 2026, an estimated $465K.
  • Amgen made up 0.6% of Soltis Investment Advisors's portfolio in Q1 2026, its #36 holding.
  • Soltis Investment Advisors first reported a position in Amgen in Q4 2020 and has held it in 21 quarters since.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Soltis Investment Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.